OncoSec Medical Inc (ONCSQ)

[TomP1]

Facts about Oncosec:

- clear hypotheses formulated by dr_Pierce
- initiation of several trials in different indications
- reverse split executed
- reduced float
- reduced possibility for market manipulation due uplisting to NASDAQ
- 13,6 mil direct offering executed, increases institutional shareholder base
- continued expansion of the company and hiring of key people
- expanded R&D into a new electroporation device that can go anywhere in the body

Key dates:

March 23: webinar hosted
May 14th: reverse split announced
May 18th: reverse split executed
May 29th: uplisting to NASDAQ
June 3d: direct offering announced
June 9th: new institutional shareholder, Sabby management
June 16th: First patient enrollment in Squamous Cell Carcinoma of the Head and Neck Phase II Clinical Trial
June 18th: new institutional shareholder, Ridgeback capital

June 26th: ONCS to be included in Russell Microcap index

Still to be announced: first patient enrollment in combination trial P2B with Keytruda